All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations.

Andrea Perez-de-Acha, Sophie Pilleron, Enrique Soto-Perez-de-Celis

Journal: Current oncology reports 2022;24(11):1377-1385

PMID: 35648341

Abstract

PURPOSE OF REVIEW

The prediction of all-cause mortality is an important component of shared decision-making across the cancer care continuum, particularly in older adults with limited life expectancy, for whom there is an increased risk of over-diagnosis and treatment.

RECENT FINDINGS

Currently, several international societies recommend the use of all-cause mortality risk prediction tools when making decisions regarding screening and treatment in geriatric oncology. Here, we review some practical aspects of the utilization of those tools and dissect the characteristics of those most employed in geriatric oncology, highlighting both their advantages and their limitations.

Address: Department of Geriatrics, Instituto Nacional de Ciencias Medicas Y Nutricion Salvador Zubiran, Vasco de Quiroga 15, Colonia Belisario Dominguez Sección XVI, Tlalpan, Ciudad de Mexico, Mexico.; Nuffield Department of Population Health, Big Data Institute, University of Oxford, Oxford, UK.; Department of Geriatrics, Instituto Nacional de Ciencias Medicas Y Nutricion Salvador Zubiran, Vasco de Quiroga 15, Colonia Belisario Dominguez Sección XVI, Tlalpan, Ciudad de Mexico, Mexico. [email protected].

DOI: 10.1007/s11912-022-01303-2

Link outs

Free resources

Medical:

https://medlineplus.gov/cancer.html

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-BRIP1-5

Subscription / membership required

Full Text Sources:

https://dx.doi.org/10.1007/s11912-022-01303-2

MeSH Terms: Humans, Aged, Neoplasms, Life Expectancy, Decision Making, Decision Making, Shared, Mass Screening, Geriatric Assessment